Loading
Latest filing published 03 Sept 2026 for Beta Bionics, Inc., €110k. Read the official filing
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
All filings by Stephen Feider on record concern Beta Bionics, Inc. The record holds 22 filings, for trades running from 27 February 2025 to 2 September 2026.
Every open-market trade on record is a sale: 11 sales worth €583k. The amount is not disclosed for 2 filings. Besides market trades, the filings include 2 share grants and 9 option exercises. Since January 2026: no purchases and 4 sales on the market.
Most recently, on 3 September 2026, the filings show an open-market sale worth €110k in Beta Bionics, Inc. Typically, a trade is published a median of 3 days after it takes place. US insiders must file a Form 4 within two business days of a trade. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
22 of 22 declarations